Endothermal heat-induced thrombosis (EHIT) is defined as propagation of a thrombus from a superficial vein into a deeper vein and is generally considered clinically insignificant if the thrombus does not propagate to the deep venous system. The condition can be treated with anticoagulation therapy, although monitoring may be sufficient, especially in less severe cases. In this paper we report on two cases of EHIT that met the criteria for indication of low molecular weight heparin until resolution of symptoms. However, the treatment actually chosen was 15 mg of rivaroxaban every 12 h and the outcomes were complete thrombus resolution in 4 weeks in Case 1 and 7 days in Case 2. Rivaroxaban may be a promising alternative for treatment of severe EHIT because the dosage regimen is simplified without compromising efficacy or safety. Prospective, randomized, controlled studies are needed to better understand EHIT and to develop more definitive recommendations on prevention and treatment options for this condition.
CITATION STYLE
De Araujo, W. J. B., Timi, J. R. R., Erzinger, F. L., & Caron, F. C. (2016, April 1). Trombose induzida pelo calor endovenoso: Relato de dois casos tratados com rivaroxabana e revisão da literatura. Jornal Vascular Brasileiro. Sociedade Brasileira de Angiologia e Cirurgia Vascular. https://doi.org/10.1590/1677-5449.009816
Mendeley helps you to discover research relevant for your work.